Meet the IMPACT Steering Committee

Following is a list of members of the IMPACT Steering Committee. By clicking on each of their names you will be able to access a brief description of that member's background and research interests:

Chief Investigator
Dr Ros Eeles, Reader in Clinical Cancer Genetics & Hon Consultant in Cancer Genetics & Oncology, The Institute of Cancer Research (ICR) & The Royal Marsden NHS Foundation Trust (RMH), UK.

IMPACT coordinators
Dr Anita Mitra, Clinical Research Fellow, ICR, UK.
Miss Elizabeth Bancroft, Research Nurse, ICR and RMH, UK.

Statistician
Professor Doug Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridge, UK.

Other Investigators:

  • Prof Dr Chris Bangma, Professor and Chairman of the Department of Urology, Erasmus Universiteit, The Netherlands.
  • Professor Diana Eccles, Consultant in Clinical Genetics, Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Professor Gareth Evans, Consultant Clinical Geneticist, Regional Genetics Service, St Mary’s Hospital, Manchester, UK.
  • Dr Alison Falconer, Consultant in Clinical Oncology, Charing Cross Hospital, London, UK.
  • Professor Christopher Foster, Professor of Cellular and Molecular Pathology, Royal Liverpool University Hospital, Liverpool, UK.
  • Dr Óskar Þór Jóhannsson, University Hospital of Iceland, Iceland.
  • Professor Hans Lilja, Attending Research Clinical Chemist, Memorial Sloan-Kettering Cancer Center, USA.
  • Professor Jan Lubinski, Consultant Clinical Geneticist, International Hereditary Cancer Centre, Pomeranian Medical Univeristy, Poland.
  • Dr Susan Peock, EMBRACE Study Co-ordinator, Strangeways Research Laboratories, Cambridge, UK
  • Dr Gad Rennert, Director, CHS National Cancer Control Centre, Israel.
  • Dr Mohnish Suri, Consultant Clinical Geneticist, Nottingham City Hospital. Nottingham, UK.